Interactions among myeloid regulatory cells in cancer
- PMID: 30003321
- PMCID: PMC11028297
- DOI: 10.1007/s00262-018-2200-6
Interactions among myeloid regulatory cells in cancer
Abstract
Mounting evidence has accumulated on the critical role of the different myeloid cells in the regulation of the cancerous process, and in particular in the modulation of the immune reaction to cancer. Myeloid cells are a major component of host cells infiltrating tumors, interacting with each other, with tumor cells and other stromal cells, and demonstrating a prominent plasticity. We describe here various myeloid regulatory cells (MRCs) in mice and human as well as their relevant therapeutic targets. We first address the role of the monocytes and macrophages that can contribute to angiogenesis, immunosuppression and metastatic dissemination. Next, we discuss the differential role of neutrophil subsets in tumor development, enhancing the dual and sometimes contradicting role of these cells. A heterogeneous population of immature myeloid cells, MDSCs, was shown to be generated and accumulated during tumor progression as well as to be an important player in cancer-related immune suppression. Lastly, we discuss the role of myeloid DCs, which can either contribute to effective anti-tumor responses or play a more regulatory role. We believe that MRCs play a critical role in cancer-related immune regulation and suggest that future anti-cancer therapies will focus on these abundant cells.
Keywords: Dendritic cells; Macrophages; Mye-EUNITER; Myeloid regulatory cells; Myeloid-derived suppressor cells; Neutrophils.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Role of myeloid regulatory cells (MRCs) in maintaining tissue homeostasis and promoting tolerance in autoimmunity, inflammatory disease and transplantation.Cancer Immunol Immunother. 2019 Apr;68(4):661-672. doi: 10.1007/s00262-018-2264-3. Epub 2018 Oct 24. Cancer Immunol Immunother. 2019. PMID: 30357490 Free PMC article. Review.
-
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity.Nat Rev Immunol. 2021 Aug;21(8):485-498. doi: 10.1038/s41577-020-00490-y. Epub 2021 Feb 1. Nat Rev Immunol. 2021. PMID: 33526920 Free PMC article. Review.
-
Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.Front Immunol. 2018 Jun 4;9:1288. doi: 10.3389/fimmu.2018.01288. eCollection 2018. Front Immunol. 2018. PMID: 29915603 Free PMC article. Review.
-
Relevance of Interferon Regulatory Factor-8 Expression in Myeloid-Tumor Interactions.J Interferon Cytokine Res. 2016 Jul;36(7):442-53. doi: 10.1089/jir.2015.0174. J Interferon Cytokine Res. 2016. PMID: 27379866 Free PMC article. Review.
-
Plasticity of myeloid-derived suppressor cells in cancer.Curr Opin Immunol. 2018 Apr;51:76-82. doi: 10.1016/j.coi.2018.03.009. Epub 2018 Mar 14. Curr Opin Immunol. 2018. PMID: 29547768 Free PMC article. Review.
Cited by
-
CD40 Ligand-CD40 Interaction Is an Intermediary between Inflammation and Angiogenesis in Proliferative Diabetic Retinopathy.Int J Mol Sci. 2023 Oct 25;24(21):15582. doi: 10.3390/ijms242115582. Int J Mol Sci. 2023. PMID: 37958563 Free PMC article.
-
Structural and functional characterization of C0021158, a high-affinity monoclonal antibody that inhibits Arginase 2 function via a novel non-competitive mechanism of action.MAbs. 2020 Jan-Dec;12(1):1801230. doi: 10.1080/19420862.2020.1801230. MAbs. 2020. PMID: 32880207 Free PMC article.
-
Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates.Cancer Immunol Immunother. 2019 Apr;68(4):687-697. doi: 10.1007/s00262-019-02302-2. Epub 2019 Jan 25. Cancer Immunol Immunother. 2019. PMID: 30684003 Free PMC article. Review.
-
Expression profiling of immune inhibitory Siglecs and their ligands in patients with glioma.Cancer Immunol Immunother. 2019 Jun;68(6):937-949. doi: 10.1007/s00262-019-02332-w. Epub 2019 Apr 5. Cancer Immunol Immunother. 2019. PMID: 30953118 Free PMC article.
-
MDSC and beyond: a symposium-in-writing on myeloid cells with immunoregulatory activity by members of the Mye-EUNITER network.Cancer Immunol Immunother. 2019 Apr;68(4):531-532. doi: 10.1007/s00262-019-02325-9. Cancer Immunol Immunother. 2019. PMID: 30887118 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources